首页> 外文期刊>Obesity surgery >Revision to malabsorptive Roux-en-Y gastric bypass (MRNYGBP) provides long-term (10 years) durable weight loss in patients with failed anatomically intact gastric restrictive operations: long-term effectiveness of a malabsorptive Roux-en-Y gastric bypass in salvaging patients with poor weight loss or complications following gastroplasty and adjustable gastric bands.
【24h】

Revision to malabsorptive Roux-en-Y gastric bypass (MRNYGBP) provides long-term (10 years) durable weight loss in patients with failed anatomically intact gastric restrictive operations: long-term effectiveness of a malabsorptive Roux-en-Y gastric bypass in salvaging patients with poor weight loss or complications following gastroplasty and adjustable gastric bands.

机译:适应不良的Roux-en-Y胃旁路手术(MRNYGBP)的修订可为解剖学上完整的胃限制性手术失败的患者提供长期(10年)的持久减肥:不良适应性的Roux-en-Y胃旁路在挽救中的长期有效性体重减轻差或胃成形术后并发胃带可调整的并发症的患者。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Twenty percent of gastric restrictive operations require revision. Conversion to Proximal Roux-en-Y gastric bypass (PRNYGBP) is associated with weight regain. Forty-one percent of these fail to achieve a body mass index (BMI) < 35. Few report follow-up (F/U) or quality of life (QOL) beyond 5 years. We report the long-term effectiveness of MRNYGBP as a revision. METHODS: Retrospective chart review of patients (1993-2005) with a failed gastric restrictive operation (S1) at least a year out from revision (S2) to a MRNYGBP: small lesser curve 22 +/- 10 (11-55) cm(3) pouch, long biliopancreatic limb, 150 cm alimentary limb, 141 +/- 24 (102-190) cm common channel. Staple-line disruptions were excluded. RESULTS: Thirty-eight (37 F, 1 M) patients aged 46 +/- 8 (17-56) years underwent conversion to a MRYGBP 8 +/- 5 (2-23) years after: gastroplasty 25, adjustable gastric band 13 for weight regain (79%), gastroesophageal reflux disease (GERD; 29%), and band problems (24%). S1 provided only 24 +/- 25% excess weight loss (EWL; 5.9 +/- 6.3 BMI drop) and caused GERD in 32% of patients (p = 0.0124). There were no deaths or leaks. BMI dropped from 41.4 +/- 7.8 to 27.3 +/- 5.6 (down 20.5 +/- 8.3 from S1), 80.1 +/- 23.3% EWL (n = 32) at year 1 (p < 0.0001). This was maintained for 10 years. BMI was 28 +/- 4 (21.5-31.9), 75.6 +/- 21.1% EWL (57.3-109.6) (n = 5) at 10 years. Super obese patients had better 9.95% EWL after S2 (p = 0.0359). QOL (5 = excellent): 4.5 +/- 0.5 (3-5). F/U: 5.1 +/- 3.3 (1-13) years with 83.3% F/U 10-year rate. Labs at 3 years (n = 10): Alb 3.8 +/- 0.4, Prot 6.8 +/- 0.6, Iron 47.6 +/- 33.3, VitD 15.1 +/- 7.43, PTH 54.5 +/- 27.2, B12 620.1 +/- 676.5, Hct 34 +/- 4.3. CONCLUSIONS: Revision MRNYGBP provides excellent durable long-term weight loss after failed gastric restrictive operations. Non-compliant patients are at a higher risk for malnutrition, anemia, and osteoporosis.
机译:背景:20%的胃限制性手术需要修订。转换为近端Roux-en-Y胃旁路(PRNYGBP)与体重增加有关。其中有41%的人体质量指数(BMI)低于35。超过5年的报告随访(F / U)或生活质量(QOL)很少。我们报告了MRNYGBP作为修订版的长期有效性。方法:回顾性图表回顾性分析了从胃镜翻修(S2)到MRNYGBP至少一年后,胃限制性手术(S1)失败的患者(1993-2005):较小的小曲线22 +/- 10(11-55)cm( 3)囊袋,长胰胆管四肢,饮食性肢体150厘米,公共通道141 +/- 24(102-190)厘米。装订线中断被排除。结果:38(37 F,1 M)患者年龄46 +/- 8(17-56)岁,在术后8 +/- 5(2-23)年接受了MRYGBP转换:胃成形术25,可调节胃带13体重恢复(79%),胃食管反流病(GERD; 29%)和束带问题(24%)。 S1仅减轻了24 +/- 25%的体重(EWL; 5.9 +/- 6.3的BMI下降),并在32%的患者中引起GERD(p = 0.0124)。没有死亡或泄漏。 BMI从第一年的41.4 +/- 7.8降至27.3 +/- 5.6(比S1下降20.5 +/- 8.3),80.1 +/- 23.3%的EWL(n = 32)(p <0.0001)。这维持了10年。在10年时,BMI为28 +/- 4(21.5-31.9),75.6 +/- 21.1%EWL(57.3-109.6)(n = 5)。超级肥胖患者在S2后的EWL改善为9.95%(p = 0.0359)。 QOL(5 =优):4.5 +/- 0.5(3-5)。 F / U:5.1 +/- 3.3(1-13)年,F / U 10年率为83.3%。 3年实验室(n = 10):Alb 3.8 +/- 0.4,Prot 6.8 +/- 0.6,铁47.6 +/- 33.3,VitD 15.1 +/- 7.43,PTH 54.5 +/- 27.2,B12 620.1 +/- 676.5,Hct 34 +/- 4.3。结论:MRNYGBP修订版在胃限制性手术失败后可提供出色的持久性长期减肥。不依从的患者营养不良,贫血和骨质疏松症的风险更高。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号